40 research outputs found
ISMAAR: Leading the global agenda for a more physiological, patient-centred, accessible and safer approaches in ART
Hyperemesis gravidarum and risk of cancer in offspring, a Scandinavian registry-based nested case–control study
Hyperemesis gravidarum and pregnancy outcomes in the Norwegian mother and child cohort – a cohort study
Hyperemesis Gravidarum is a Syndrome of Metabolic and Endocrine Disturbances: A Case Description
A short narrative review of the feasibility of adopting mild ovarian stimulation for IVF as the current standard of care
MILD ovarian stimulation with GnRH-antagonist vs. long protocol with low dose FSH for non-PCO high responders undergoing IVF: a prospective, randomized study including thawing cycles
Ovarian stimulation for IVF: mild approaches
Item does not contain fulltextIn contrast to current approaches, the aim of mild stimulation is to develop safer and more patient-friendly protocols in which the risks of the treatment as a whole are minimized. Mild stimulation is defined as the method when exogenous gonadotropins are administered at lower doses, and/or for a shorter duration in GnRH antagonist co-treated cycles, or when oral compounds (antiestrogens, aromatase inhibitors) are used for ovarian stimulation for IVF, with the aim of limiting the number of oocytes obtained to fewer than eight. In this chapter we discuss the relevant physiology of follicle development, the development of milder stimulation protocols, the implications of mild stimulation, the current state of affairs, and future developments